By Jacob Gronholt-Pedersen and Patrick Wingrove COPENHAGEN, Nov 4 (Reuters) – Obesity drugmaker Novo Nordisk raised its 2026 outlook for the third time this year on Wednesday as quarterly sales of its
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Nov 4 (Reuters) - CVS Health said on Wednesday it would split its retail pharmacy…
Nov 4 (Reuters) - CVS Health said on Wednesday it will split into two companies,…
By Purvi Agarwal and Johann M Cherian Nov 4 (Reuters) - Data center stocks slipped…
Nov 4 (Reuters) - CVS Health said on Wednesday it will split into two companies,…
VIDEO SHOWS: SOUNDBITES FROM FORMER HEAD OF THE FIFA GOVERNANCE COMMITTEE MIGUEL MADURO ON GIANNI…
Nov 4 (Reuters) - India's Apollo Tyres reported a 13.3% increase in second-quarter profit on…